MMSI vs VCYT: Which Stock Is the Better Buy?
Merit Medical Systems, Inc. and Veracyte, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
AI verdict — MMSI vs VCYT, read from the filings
The stronger business, the cheaper stock, and the risks — synthesised from both companies’ SEC filings, every figure computed not guessed. Not investment advice.
| Merit Medical Systems, Inc. (MMSI) | Veracyte, Inc. (VCYT) | |
|---|---|---|
| Market cap | $4.0B | $3.9B |
| Revenue (latest FY) | $1.52B | $517.14M |
| Net income (latest FY) | $128.49M | $66.35M |
| Revenue growth (5y CAGR) | 9.5% | 34.5% |
| Net margin | 8.5% | 12.8% |
| Return on equity | 8.1% | 5.1% |
| P/E ratio | 28.8 | 44.9 |
| Dividend yield | — | — |
| Profitable years (of last 10) | 9 | 2 |
| Positive free cash flow | Yes | Yes |
Verify the comparison
Use the filing period and source shown by each tool before treating two figures as comparable.
See the full MMSI vs VCYT breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open MMSI's full financials → Open VCYT's full financials →More comparisons
Frequently asked questions
Which is bigger, MMSI or VCYT?
Merit Medical Systems, Inc. is larger by market capitalization — $4.0B versus $3.9B.
Which grows faster, MMSI or VCYT?
Over the last five fiscal years, Veracyte, Inc. grew revenue faster — 34.5%/yr versus 9.5%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.
Keep exploring
MMSI fundamentals → · VCYT fundamentals → · All 1,500+ companies → · Free screener →